What is MapLight Therapeutics, Inc. 's accrued expenses?

MapLight Therapeutics, Inc. (MPLT) reported accrued expenses of $10.18M in Q1 2026.

What does accrued expenses mean?

Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

MapLight Therapeutics, Inc. MPLT Accrued Expenses

Accrued Expenses at other companies

Acadia PharmaceuticalsACAD

$293.28M+3.1%

LBR

LB Pharmaceuticals Inc Common StockLBRX

$3.06M—

MeiraGTx Holdings plcMGTX

$105.11M+18,022%

Alto NeuroscienceANRO

$2M-1.8%

Zevra Therapeutics, Inc.ZVRA

$1.41M-58.6%

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B+100%

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Current ratio22.9×—

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's accrued expenses?: MapLight Therapeutics, Inc. (MPLT) reported accrued expenses of $10.18M in Q1 2026.
What does accrued expenses mean?: Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.